Somatuline (lanreotide) Access in Manitoba & Alberta

//Somatuline (lanreotide) Access in Manitoba & Alberta

Somatuline (lanreotide) Access in Manitoba & Alberta

As we advised previously, in July of this year the Manitoba government issued a bulletin…/bulletins/bulletin93.pdf that indicated a change in the listing for Somatuline (from 1 to 3 and no access for NET patients in Manitoba). While CNETS Canada did not get a satisfactory response from the Assistant Deputy Minister Provincial Policy and Programs Division on the reason for the change, we have learned recently that a reversal of this decision is forthcoming.   If there are any Manitoba patients facing access issues we would like to hear from you.   Please contact

Somatuline is currently not covered for NETs in Alberta.  Any Albertan patients who are experiencing issues gaining access to Somatuline please reach out to

By | 2018-05-07T18:28:11+00:00 October 2nd, 2017|Treatment News|Comments Off on Somatuline (lanreotide) Access in Manitoba & Alberta

About the Author: